Shares of Rain Oncology Inc. (NASDAQ:RAIN – Free Report) have been assigned a consensus recommendation of “Hold” from the twelve research firms that are covering the firm, MarketBeat reports. Ten analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month price target among […]
Tang Capital Management LLC acquired a new stake in Elevation Oncology, Inc. (NASDAQ:ELEV – Get Rating) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 479,854 shares of the company’s stock, valued at approximately $456,000. Tang Capital Management LLC […]
SVB Securities upgraded shares of Elevation Oncology (NASDAQ:ELEV – Get Rating) from a market perform rating to an outperform rating in a report issued on Tuesday, The Fly reports. SVB Securities currently has $8.00 target price on the stock, up from their previous target price of $5.00. Separately, Wedbush reiterated an outperform rating and set […]
SVB Leerink upgraded shares of Elevation Oncology (NASDAQ:ELEV – Get Rating) from a market perform rating to an outperform rating in a research report report published on Tuesday morning, PriceTargets.com reports. A number of other analysts have also recently issued reports on ELEV. Wedbush restated an outperform rating and set a $4.00 price objective on […]
Roth Capital lowered shares of Rain Oncology (NASDAQ:RAIN – Get Rating) from a buy rating to a neutral rating in a report published on Tuesday morning, PriceTargets.com reports. A number of other research analysts have also recently weighed in on the company. Oppenheimer cut Rain Oncology from an outperform rating to a market perform rating […]